Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Monomeric peptide multi-agonist targeting the GLP1 receptor and NPY receptors

Monomeric peptide multi-agonist targeting the GLP1 receptor and NPY receptors

US Patent 12384825 · Granted Aug 12, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Assay for detection of an A2E-Saposin B complex2025
Peptide drug improvement using vitamin B12 and Haptocorrin binding substrate con2024
Glycemic control using intrinsic factor bound to a vitamin B12 conjugate of a gl2023
Methods of synthesis for a thioketal diol2023
Peptide drug improvement using vitamin B12 and haptocorrin binding substrate con2021
Methods of synthesis for a thioketal diol2021
Saposin B binds the lipofuscin bisretinoid A2E and prevents its enzymatic and ph2020
Compositions and methods for enhancing peptide stability against protease digest2020
Preventing central nervous system induced nausea through use of vitamin B12 conj2020
Coagonists of glucagon-like peptide 1 receptor and neuropeptide Y2 receptor2018
Methods and systems for zinc delivery using intrinsic factor or haptocorrin2016
Butanal production using engineered Streptomyces coelicolor2015